Prescription patterns and treatment outcomes of <scp>MDR</scp>‐<scp>TB</scp> patients treated within and outside the <scp>N</scp>ational <scp>T</scp>uberculosis <scp>P</scp>rogramme in <scp>P</scp>ham <scp>N</scp>goc <scp>T</scp>hach hospital, <scp>V</scp>iet <scp>N</scp>am

Abstract

The treatment outcomes of patients with MDR-TB in the GLC group were significantly better than in the non-GLC group. Reasons for the high default rate in non-GLC patients with MDR-TB must be further investigated.